Terms: = Lymphoma AND FES, FPS, 2242, ENSG00000182511, P07332 AND Prognosis
7 results:
1. Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia.
Oliveira T; Zhang M; Joo EJ; Abdel-Azim H; Chen CW; Yang L; Chou CH; Qin X; Chen J; Alagesan K; Almeida A; Jacob F; Packer NH; von Itzstein M; Heisterkamp N; Kolarich D
Theranostics; 2021; 11(19):9519-9537. PubMed ID: 34646384
[TBL] [Abstract] [Full Text] [Related]
2. Clinical characteristics and survival of extranodal natural killer/T-cell lymphoma: a single-center 12-year retrospective analysis.
Chen Y; Luo L; Zheng X; Fu H; Yang X; Huang W; Chen L; Zheng Z; Zheng J; Yang T; Liu T; Hu J
Leuk Lymphoma; 2020 Dec; 61(14):3306-3318. PubMed ID: 32820684
[TBL] [Abstract] [Full Text] [Related]
3. Limiting surveillance imaging for patients with lymphoma in remission: a mixed methods study leading to a Choosing Wisely recommendation.
Paltiel O; Raviv Sharabi G; Tzemach R; Rechavi T; Trachtenberg E; Goldschmidt N; Dann EJ; Bar-Shalom R
BMJ Qual Saf; 2021 Apr; 30(4):300-310. PubMed ID: 32467340
[TBL] [Abstract] [Full Text] [Related]
4. [Acute intestinal intussusception revealing intestinal T-cell lymphoma in adults].
Hasnaoui H; El Bouhaddouti H; Mouaqit O; Benjelloun EB; Ousadden A; Taleb KA
Pan Afr Med J; 2019; 33():153. PubMed ID: 31558950
[TBL] [Abstract] [Full Text] [Related]
5. fes-related tyrosine kinase activates the insulin-like growth factor-1 receptor at sites of cell adhesion.
Stanicka J; Rieger L; O'Shea S; Cox O; Coleman M; O'Flanagan C; Addario B; McCabe N; Kennedy R; O'Connor R
Oncogene; 2018 Jun; 37(23):3131-3150. PubMed ID: 29540831
[TBL] [Abstract] [Full Text] [Related]
6. [A clinicopathologic and prognosis study of Epstein-Barr virus positive diffuse large B-cell lymphoma in west-southern China].
Ye YX; Zhang WY; Li GD; Liu WP; Liu YM; Lin L; Liao DY; Guo J; Xie CY; Jiang WJ; Liu L; Zhang SF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):652-7. PubMed ID: 25286694
[TBL] [Abstract] [Full Text] [Related]
7. [Treatment outcomes and prognostic analyses of relapsed or refractory T-cell non-Hodgkin's lymphoma].
Gao Y; Huang HQ; Lin XB; Cai QQ; Pan ZH; Wang BF; Bu Q
Ai Zheng; 2007 Aug; 26(8):909-13. PubMed ID: 17697558
[TBL] [Abstract] [Full Text] [Related]
